SEC Tracker
Get the app

MAIA Biotechnology MAIA

MAIA Biotechnology Biotechnology reported a net loss of $7.18 million

MAIA Biotechnology (MAIA) filed a 10-Q with the SEC on Nov 9, 2026, 5:01 pm ET. Source: the filing on SEC EDGAR.

Form
10-Q
Filed
Importance
Notable
  1. Net loss: $7.18 million for the three months ended Sep 30, 2026
  2. Diluted EPS: -$0.12 for the three months ended Sep 30, 2026
  3. Cash and equivalents: $21.34 million at Sep 30, 2026

Written from the 10-Q on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Going-concern warning is new

“Based on the cost control measures implemented, the Company believes the substantial doubt to continue as a going concern for at least 12 months from the date these financial statements were issued is reasonably alleviated.”
In the notes to the financial statements. Read it in the filing 10-Q on EDGAR

First warning: the prior 10-Q (filed Aug 10, 2026) had no going-concern warning. Prior report Prior on EDGAR

Quoted from the filing.

Get an email when MAIA Biotechnology files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.